Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Supreme Court Hears Arguments on Vaccine Liability Law
WSJ Online
Wednesday, October 13, 2010 - 11:52am
tags:
Supreme Court, vaccines
Abbott Labs Goes Ex-Dividend, Trades Without Payout
Bloomberg
Wednesday, October 13, 2010 - 11:51am
tags:
Abbott Laboratories, dividends
Warner Chilcott Soars As FDA OKs New Drug
Investors.com
Tuesday, October 12, 2010 - 9:56pm
tags:
Warner Chilcott, FDA, osteoporosis, Actonel, Atelvia
Pfizer's Antidepressant Reboxetine Doesn't Quell Illness, Analysis Finds
Bloomberg
Tuesday, October 12, 2010 - 9:54pm
tags:
Pfizer, antidepressants, reboxetine
FDA's Top Q4 Blockbuster Drug Decisions
Fierce Biotech
Tuesday, October 12, 2010 - 11:26am
tags:
Linjeta, Biodel, Afrezza, MannKind, FDA, Benlysta, Human Genome, GSK, Bydureon, Eli Lilly, Amylin, Alkermes, Brilinta, AstraZeneca, Pradaxa, Boehringer Ingelheim, Qnexa, Vivus, Contrave, Orexigen, ipilimumab, Bristol-Myers Squibb, Merck KGaA, cladribine
New Pfizer drug may add to mix in lung cancer war
Reuters
Tuesday, October 12, 2010 - 11:22am
tags:
lung cancer, Pfizer
Halozyme cutting 25 percent of its work force
Yahoo/AP
Tuesday, October 12, 2010 - 11:12am
tags:
layoffs, Halozyme
For Dendreon’s Provenge, a New Competitor Looms
WSJ Online
Tuesday, October 12, 2010 - 11:07am
tags:
Dendreon, Provenge, prostate cancer, abiraterone, JNJ
Big Pharma, Soros in emerging-markets deals
Fierce Pharma
Tuesday, October 12, 2010 - 11:03am
tags:
Sihuan, China, George Soros, India, Paras
10 Pharmaceutical Stocks With Up to 88% Upside
TheStreet.com
Tuesday, October 12, 2010 - 11:01am
tags:
Novartis, Allergan, Shire, AstraZeneca, Abbott Laboratories, Merck, Pfizer, Teva Pharmaceuticals, Warner Chilcott, Valeant Pharmaceuticals
Pfizer buyout offer sends King shares up 39%
Marketwatch
Tuesday, October 12, 2010 - 10:58am
tags:
Pfizer, King, M&A
Plavix May Get A Boost From A Curious Study
Pharmalot
Tuesday, October 12, 2010 - 9:20am
tags:
Plavix, Sanofi, Bristol-Myers Squibb
Novartis Paid Doc Who Urged Use of Seizure Meds on Bipolar Kids
BNET Pharma
Tuesday, October 12, 2010 - 9:03am
tags:
physicial payments, Novartis, bipolar disorder Trileptal
TAP deal with Novartis brings ImmunoGen US$45 million upfront
Pharma Times, UK
Tuesday, October 12, 2010 - 9:02am
tags:
TAP, Novartis, Immunogen
Who Is Getting a Windfall From Pfizer-King Pharmaceuticals?
WSJ Online
Tuesday, October 12, 2010 - 9:00am
tags:
Pfizer, King, M&A
Will Access Pharma Keep Trending Higher?
Seeking Alpha
Tuesday, October 12, 2010 - 9:00am
tags:
Access Pharmaceuticals
Pfizer to Buy King Pharmaceuticals for $3.6 Billion
NY Times, NY
Tuesday, October 12, 2010 - 8:55am
tags:
Pfizer, M&A, King
Crucell Rejects Shareholder Criticism Over J&J Takeover Bid
Seeking Alpha
Tuesday, October 12, 2010 - 8:54am
tags:
JNJ, Crucell, M&A, shareholders
Merck, Lundbeck in venture on bipolar-mania drug
Marketwatch
Tuesday, October 12, 2010 - 8:53am
tags:
bipolar disorder, mania, Merck, Lundbeck, Sycrest
All New Biotech Specs
CNBC
Monday, October 11, 2010 - 8:23pm
tags:
biotech, Genzyme, Sanofi, Biomarin, Alexion

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.